Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.

Slides:



Advertisements
Similar presentations
CANCER CHEMOTHERAPY. Anti Cancer drugs: 1.Historically derived small molecules. Target DNA structure or segregation of DNA- Conventional chemotherapy.
Advertisements

A trial for women with –‘Triple negative’ breast cancer (TNBC) –Localised to breast +/- lymph nodes –Recommended standard treatment involves NEPTUNE Taxane.
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
The origin of metastatic disease: clues from genomics 7/13/2011.
Expression profiles for prognosis and prediction Laura J. Van ‘t Veer The Netherlands Cancer Institute, Amsterdam.
Microarrays Dr Peter Smooker,
Public data - available for projects 6 data sets: –Human Tissues –Leukemia –Spike-in –FARO compendium – Yeast Cell Cycle –Yeast Rosetta Find one yourself.
Microarrays and Cancer Segal et al. CS 466 Saurabh Sinha.
1 April, 2005 Chapter C4.1 and C5.1 DNA Microarrays and Cancer.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
DNA Microarrays Examining Gene Expression. Prof. GrossBiology 4 DNA MicroArrays DNA MicroArrays use hybridization technology to examine gene expression.
Gene therapy progress and prospects cancer. Gene Therapy Primary challenge for gene therapy – Successfully delivery an efficacious dose of a therapeutic.
Genomics Lecture 7 By Ms. Shumaila Azam. Tumor Tumor – abnormal proliferation of cells that results from uncontrolled, abnormal cell division A tumor.
Analysis of microarray data
Presented by Karen Xu. Introduction Cancer is commonly referred to as the “disease of the genes” Cancer may be favored by genetic predisposition, but.
Metastatic Breast Cancer: One Size Does Not Fit All Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service MSKCC.
Paola CASTAGNOLI Maria FOTI Microarrays. Applicazioni nella genomica funzionale e nel genotyping DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE.
Malignant Melanoma and CDKN2A
Gene expression profiling identifies molecular subtypes of gliomas
Molecular Biomarkers in Radiotherapy of Cervical Cancer A collaboration project between Department of Gynecologic Oncology and Department of Radiation.
Fundeni Centre for Immunogenetics & Virology
Apostolos Zaravinos, Myrtani Pieri, Nikos Mourmouras, Natassa Anastasiadou, Ioanna Zouvani, Dimitris Delakas, Constantinos Deltas Department of Biological.
Identification of network motifs in lung disease Cecily Swinburne Mentor: Carol J. Bult Ph.D. Summer 2007.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
Analysis and Management of Microarray Data Dr G. P. S. Raghava.
Table S1. Characteristics of breast tumor and normal breast tissue samples. Relevant characteristics of breast tumor and normal breast tissue samples analyzed.
CDNA Microarrays MB206.
Finish up array applications Move on to proteomics Protein microarrays.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
Huidi Liu, M.D. & Ph.D Genomics Research Centre Harbin Medical University, China Reduced expression of SOX7 in ovarian cancer: a novel.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
Microarrays and Gene Expression Analysis. 2 Gene Expression Data Microarray experiments Applications Data analysis Gene Expression Databases.
Quantification of Membrane and Membrane- Bound Proteins in Normal and Malignant Breast Cancer Cells Isolated from the Same Patient with Primary Breast.
Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.
J. Fernebro, P. Francis, P. Edén, Å. Borg, I. Panagopoulos, F. Mertens, J. Vallon-Christersson, M. Åkerman, N. Mandahl, M. Nilbert Departments of Oncology,
MCB 317 Genetics and Genomics Topic 11 Genomics. Readings Genomics: Hartwell Chapter 10 of full textbook; chapter 6 of the abbreviated textbook.
Gene Expression Analysis. 2 DNA Microarray First introduced in 1987 A microarray is a tool for analyzing gene expression in genomic scale. The microarray.
OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.
Nuria Lopez-Bigas Methods and tools in functional genomics (microarrays) BCO17.
Exploring Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Through.
ANALYSIS OF GENE EXPRESSION DATA. Gene expression data is a high-throughput data type (like DNA and protein sequences) that requires bioinformatic pattern.
Exploring Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Through.
Case Study: Characterizing Diseased States from Expression/Regulation Data Tuck et al., BMC Bioinformatics, 2006.
Genes and Chips. Genes….  The proper and harmonious expression of a large number of genes is a critical component of normal growth and development and.
Eigengenes as biological signatures Dr. Habil Zare, PhD PI of Oncinfo Lab Assistant Professor, Department of Computer Science Texas State University 5.
NCode TM miRNA Analysis Platform Identifies Differentially Expressed Novel miRNAs in Adenocarcinoma Using Clinical Human Samples Provided By BioServe.
Gene Expression Profile in Proliferation and Apoptosis of Human Hepatic Stellate Cell Using Microarray 신혜원 병리학교실.
The transcriptional program in the response of human fibroblasts to serum Iyer et. al. (1999) Presented by: Paya Sarraf Brendan Finicle.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
*** * * * Figure S1 Supplementary Figure 1. Analysis of JARID1A–D mRNA levels showed that JARID1D knockdown had insignificant or weak effects on expression.
Eigengenes as biological signatures Dr. Habil Zare, PhD PI of Oncinfo Lab Assistant Professor, Department of Computer Science Texas State University 3.
R2 김재민 / Prof. 정재헌 Journal conference 1.
Yuna Jo. Introduction Prostate cancer (PCa) continues to burden the Western world with its high rates of incidence and mortality despite the.
Intermediate Atypical Carcinoma: Novel Histologic Subtype of mCRPC in Patients Resistant to Androgen Receptor Agonists CCO Independent Conference Highlights.
GENETIC BIOMARKERS.
FINAL PROJECT- Key dates
Loyola Marymount University
Gene expression.
The student is expected to: 5A describe the stages of the cell cycle, including deoxyribonucleic acid (DNA) replication and mitosis, and the importance.
RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer Tamara A. Sussman MD1, Mohamed Abazeed MD PhD1,
Breast Cancer By:Nina Bullock.
Loyola Marymount University
Transcriptional Signature of Histone Deacetylases in Breast cancer
Microarray Gene Expression Analysis of Fixed Archival Tissue Permits Molecular Classification and Identification of Potential Therapeutic Targets in Diffuse.
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Presentation transcript:

Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez Janelle N. Ruiz Biology Department of Biology Loyola Marymount University April 11, 2010 Eva, La Tullippe, Jaya Satagopan, Alex Smith, Howard Scher, Peter Scardino, Victor Reuter, William Gerald. Department of Pathology

Outline I.Differences in gene expression profiles between progressive and non-progressive tumors can explain the mechanism of disease. II.Microarray analysis was used to determine differential gene expression III.Differentially expressed genes between metastatic and primary tumors were found: I.Cell Cycle Regulation II.Mitosis III.Signaling IV.DNA Replication IV.Metastatic tumors had higher proliferation index than primary tumors. V.Both previously-identified and novel differentially expressed genes were identified.

Importance of Investigating Gene Expression Profiles of Prostate Cancer Tumors Carcinoma of the prostate is the most common cancer in the United States Tumors can be classified as being either metastasized or localized Development of metastatic disease leads to death. Improving tumor classification and therapy can be achieved by identifying –Genes –Gene expression profiles –Biological pathways

Genome Wide Expression Analysis of Primary and Metastatic Prostate Cancers Tissues samples were taken from: –3 Non cancerous Patients –23 Primary Prostate Cancer Patients –9 Metastatic Prostate cancer Patients Collected as biopsies from Analysis was preformed with Affymetrix chips Within chip and between chip normalization was carried out by multiplying expression values such that the average expression was 2500 They considered genes to be differentially expressed if they differed by 3 fold between two groups They took the Log 10 of the ratio of the means.

Differences in Clinical and Pathological Features Between Primary and Metastatic Tumors

Clustering Shows That Primary Tumors Have A Different Expression Profile Than The Metastatic Tumors

Genes Involved in Cell Cycle Regulation, DNA Replication and Repair, and Mitosis Were Highly Differentially Expressed in Metastatic Tumors

Genes Involved in Signaling and Signal Transduction Were Differentially Expressed in Metastatic Tumors

Genes Involved in Transcriptional Regulation and Cell Adhesion Were Highly Differentially Expressed in Metastatic Tumors

Metastatic Tumors Present Higher Proliferation Index Than Primary Tumors

Quantitative RT-PCR Confirms Relative Expression Values Observed From Microarray Experiment

Microarray Data Reveals Both Previously-Identified and Novel Differentially Expressed Genes Between Primary and Metastatic Tumors Previous studies have revealed similar patterns of gene expression. Differentially expressed genes of functional pathways previously implicated in aggressive disease Analysis reveled hundreds of poorly characterized gene clusters that likely represent novel genes of unknown function –Biological activity of these genes can be inferred from other known genes with shared expression patterns

Determining Function of Unknown Genes May Identify Potential Therapeutic Targets Few prior studies have used high-throughput gene expression analysis to study prostate cancer metastasis Some of genes differentially expressed may identity critical functional pathways: –Example: MYBL2 may signify critical component of cell cycle regulation in metastatic cancer Further studies would determine the function of unknown genes and identify potential therapeutic targets for treatment.

References LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, and Gerald L. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002 Aug 1; 62(15)